Olfactory Training for Post-COVID Parosmia Recovery
Post-COVID parosmia, the distortion of smell where familiar scents become unpleasant, remains a challenging long-term effect for many. Understanding how recovery works in the brain is essential for developing effective interventions. New neuroimaging research reveals the specific neural mechanisms behind the most recommended treatment: olfactory training.
Key Takeaways
- A 2026 fMRI study from TU Dresden shows olfactory training physically rewires the brain in patients, reactivating key smell-processing regions like the orbitofrontal cortex and amygdala after a 12-week program.
- Patient recovery is characterized by slower, broader neural responses, indicating a compensatory mechanism as the olfactory system restores itself.
- Combining structured olfactory training with a free-choice, patient-selected scent protocol and pharmacotherapy (like oral corticosteroids) can yield better outcomes than training alone, according to a retrospective Japanese study.
- The evidence supports a regimen of twice-daily, short-duration exposure to four distinct scent categories (rose, lemon, eucalyptus, clove) as a foundational, neuroplasticity-driving practice.
Olfactory Training Restores Brain Function Through Delayed Network Activation
Research led by Hanani Abdul Manan at TU Dresden’s Smell and Taste Clinic used a novel fMRI technique to track brain changes in 20 patients with olfactory dysfunction. Before a 12-week olfactory training program, patients showed weak or absent activity in three critical regions: the right insula, amygdala, and orbitofrontal cortex (OFC). These areas govern smell perception, emotional response, and scent identification. After training, clear activation returned. However, the recovery pattern was distinct. The patients’ hemodynamic responses were delayed and broader compared to healthy controls. This suggests the recovering brain engages olfactory networks more extensively and slowly, a compensatory “gain-of-function” as it rebuilds neural synchrony. In contrast, healthy brains refined their responses, becoming more efficient. This work provides direct imaging evidence that olfactory training induces state-dependent neural plasticity, physically restoring the pathways damaged by viral infection.
Free-Choice Scents and Pharmacotherapy May Enhance Standard Training
While structured training is effective, a 2026 retrospective analysis from Mie University suggests its benefits can be amplified. Morishita and colleagues evaluated outcomes for patients with post-viral olfactory dysfunction. They found that a protocol combining standard olfactory training with a “free-choice” element—where patients also train with a self-selected, personally pleasant scent—alongside pharmacotherapy like oral corticosteroids, produced better subjective and objective recovery rates than training alone. The free-choice component likely improves adherence and emotional engagement, activating the amygdala and OFC more robustly, which are directly tied to scent memory and hedonic evaluation. This aligns with the science of the Proustian moment, where personal scent associations trigger powerful memory networks. Combining this personalized approach with anti-inflammatory medication addresses both neural retraining and potential residual inflammation.
Practical Protocol Recommendations for Recovery from Parosmia
For perfumers and fragrance chemists advising clients, or for individuals pursuing recovery, the evidence points to a multi-faceted protocol. The foundational practice remains twice-daily olfactory training with the four core scents: phenyl ethyl alcohol (rose), citral (lemon), eucalyptol (eucalyptus), and eugenol (clove). Each represents a major odor category, ensuring broad neural recruitment. Exposure should be brief but focused; sniff each scent for about 20 seconds with full attention. Based on the Mie University findings, augmenting this with a fifth, personally meaningful scent—a favorite perfume, coffee, or a specific essential oil like lavender—can boost motivation and emotional salience. For cases of persistent parosmia, consultation with an otolaryngologist for assessment and potential short-term pharmacotherapy (e.g., oral corticosteroids or intranasal sodium citrate) is recommended, as it may work additively with neural training.
The chemistry of the chosen materials matters. Use pure, food-grade, or perfumery-grade materials to avoid confounding irritants. For example, ensure lemon scent comes from purified citral rather than a complex oil containing skin-sensitizing compounds like limonene oxides. Understanding fragrance sensitization chemistry is key to selecting safe training agents. Furthermore, the delayed brain response seen in the fMRI study implies patience is necessary; a minimum commitment of 12 weeks is required to observe measurable neural change, with many patients continuing for 6 months or longer.
Implications for Fragrance Formulation and Client Guidance
This research has direct applications for the fragrance industry. First, it validates the profound link between scent and brain structure. Formulators should recognize that their creations engage deep, plastic neural circuits in the OFC and amygdala. For clients experiencing parosmia, advise against abandoning scent; instead, guide them toward gentle, familiar, and structurally simple aromas as part of a retraining regimen. Scents associated with positive memories may be particularly effective due to their strong limbic system connections, a topic explored in our article on smell and depression. Second, the studies highlight that recovery is an active, learned process. There is no passive cure. The brain must be retrained through repeated, mindful exposure. While promising, the research has limitations. Sample sizes were modest, and the optimal combination of pharmacotherapy agents requires more standardized trials. Individual variability in damage and recovery remains high.
Olfactory training is a direct application of neuroplasticity. Post-COVID parosmia recovery involves the slow, compensatory re-engagement of specific olfactory networks, a process that can be supported by a structured, patient-augmented, and potentially pharmacologically-assisted protocol. For professionals in fragrance, this underscores the material power of scent as a tool for neurological repair.
Sources:
https://pubmed.ncbi.nlm.nih.gov/41881421/
https://pubmed.ncbi.nlm.nih.gov/41763121/
https://pubmed.ncbi.nlm.nih.gov/41559316/
Fragrance Studio lets you test materials against parosmia recovery research directly — no spreadsheet juggling, with data sourced from Fenaroli, IFRA, PubChem and more.
